iPSC-Derived Cells
bit.bio is a synthetic biology company developing a scalable technology platform capable of producing consistent batches of every human cell. bit.bio iPSC-derived cells are generated by opti-oxTM reprogramming, providing easy to use, scalable and consistent human cellular models for research, disease modelling and High-Throughput Screening
Elixirgen Scientific’s human iPSC-derived cells are created using human iPS cells made available through a license from The California Institute for Regenerative Medicine (CIRM). All of our iPSC-derived cells are differentiated using our proprietary technology that utilizes a potent cocktail of key transcription factors to transform iPSCs into high-quality, differentiated cells. Some of the advantages include (1) Highly pure population (2) No genetic footprint (3) Multiple donors and disease types to choose from